Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats

Neuroscience Letters
Trisha A Jenkins

Abstract

The extensive clinical experience of angiotensin converting enzyme inhibitors and angiotensin AT(1) receptor antagonists as antihypertensive agents provide numerous examples of anecdotal evidence of improvements in cognition and mood. This study aimed to determine the effect of chronic treatment with the angiotensin converting enzyme inhibitor, perindopril, and the angiotensin AT(1) receptor antagonist, candesartan, on central neurotransmitter levels in the rat. Perindopril (1.0mg/kg/day) or candesartan (10mg/kg/day) was administered via the drinking water at for 1 week, while controls received water alone. At the end of treatment rats were sacrificed, brains removed and discrete regions dissected and analysed for noradrenaline, dopamine and its major metabolites, and serotonin content. As shown previously we found an increase in striatal dopamine levels after perindopril treatment, though this did not extend to the mesolimbic system with neurotransmitter levels unchanged in the hippocampus, nucleus accumbens and frontal cortex. Conversely, candesartan administration produced no change in dopamine, but significant decreases in both DOPAC and HVA in the striatum. In addition chronic candesartan infusion produced a significant in...Continue Reading

References

Feb 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·L P DwoskinL A Cassis
May 1, 1992·Endocrine Reviews·J M Saavedra
Nov 15, 1984·Biochemical Pharmacology·D GantenT Unger
Feb 15, 1980·The Journal of Comparative Neurology·R LoyR Y Moore
May 1, 1995·Journal of Chemical Neuroanatomy·F M RogersonF A Mendelsohn
Mar 1, 1997·Journal of Neurochemistry·T A JenkinsS Y Chai
Oct 10, 1998·Brain Research Bulletin·A M AllenF A Mendelsohn
Nov 20, 1998·Methods and Findings in Experimental and Clinical Pharmacology·M Hiramatsu, T Kameyama
Jul 28, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J P VoigtH Fink
Mar 22, 2002·European Journal of Pharmacology·Paul R Gard
Apr 6, 2002·Stroke; a Journal of Cerebral Circulation·J C de la Torre
Jul 12, 2002·Journal of Neural Transmission·K A Jellinger
Sep 7, 2002·Stroke; a Journal of Cerebral Circulation·Donald R Royall
Apr 2, 2003·Neuroscience and Biobehavioral Reviews·Angela J Grippo, Alan Kim Johnson
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·M J McKinleyS Y Chai
Sep 25, 2003·Neurological Research·Ingmar Skoog, Deborah Gustafson
Mar 5, 2004·Expert Opinion on Therapeutic Targets·Paul R Gard
Feb 23, 2005·Expert Review of Cardiovascular Therapy·Roberto Ferrari
Apr 28, 2005·Expert Review of Neurotherapeutics·Paul R Gard, Jennifer M Rusted
May 5, 2005·Brain Research·Jörg-Peter VoigtHeidrun Fink
Aug 3, 2005·Cellular and Molecular Neurobiology·Juan M Saavedra
May 31, 2006·Expert Opinion on Investigational Drugs·Bernard M Y Cheung
Dec 28, 2006·CNS Drugs·Mona BoulesElliott Richelson
Mar 16, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ettore Ambrosioni
Mar 17, 2007·Lancet Neurology·Patrick G Kehoe, Gordon K Wilcock
Dec 1, 2007·Clinical Interventions in Aging·Toni L RipleyRobin E Germany
Dec 11, 2007·Trends in Cognitive Sciences·Roshan CoolsTrevor W Robbins
Dec 28, 2007·Pharmacological Reviews·Klaus B Fink, Manfred Göthert

❮ Previous
Next ❯

Citations

Oct 22, 2013·Current Psychiatry Reports·Colin N Haile, Thomas R Kosten
Nov 24, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Giovambattista De SarroEmilio Russo
Jul 14, 2010·Pharmacology, Biochemistry, and Behavior·J-P VoigtA Rex
Jun 4, 2013·Neuroscience·J T CorthellP Q Trombley
Jul 31, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anjana Bali, Amteshwar Singh Jaggi
Jul 30, 2014·Frontiers in Neuroanatomy·Jose L Labandeira-GarcíaAna I Rodríguez-Perez
Oct 30, 2012·Journal of the Renin-angiotensin-aldosterone System : JRAAS·K V Anil KumarKilari Eswar Kumar
Jan 15, 2017·European Journal of Pharmacology·Anna WzgardaBeata J Stanisz
Feb 22, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Linhong JiangXiaobo Cen
Sep 5, 2012·Journal of Receptor and Signal Transduction Research·Recep SutcuNamik Delibas
Mar 31, 2016·British Journal of Pharmacology·Jérémie NeastaJean Martinez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.